(OS) Introduction: Rhoton Family Lecture

Disclosure(s):

Adam S. Arthur, MD, MPH: Arsenal Medical: Consultant (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bend IT Technologies, Ltd.: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Ownership Interest (Ongoing); Cerenovus: Consultant (Ongoing); Endostream Medical : Ownership Interest (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neurogami: Stock Shareholder (excluding mutual funds) (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Ownership Interest (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Ownership Interest (Ongoing); Serenity Medical, Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker Neurovascular: Consultant (Ongoing), Grant/Research Support (Ongoing); Synchron Inc: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC: Stock Shareholder (excluding mutual funds) (Ongoing); Viz.ai, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)